| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10017614 | HBV | ENSG00000259207.10 | protein_coding | ITGB3 | No | No | 3690 | P05106 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ITGB3 |
|---|---|
| DrugBank ID | DB04863 |
| Drug Name | Lefradafiban |
| Target ID | BE0001155 |
| UniProt ID | P05106 |
| Regulation Type | |
| PubMed IDs | 11250974 |
| Citations | Akkerhuis KM, van Den Brand MJ, van Der Zwaan C, Peels HO, Suryapranata H, van Der Wieken LR, Stibbe J, Hoffmann J, Baardman T, Deckers JW, Simoons ML: Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty. Heart. 2001 Apr;85(4):444-50. |
| Groups | Investigational |
| Direct Classification | Biphenyls and derivatives |
| SMILES | [H][C@@]1(COC2=CC=C(C=C2)C2=CC=C(C=C2)C(=N)NC(=O)OC)C[C@@H](CC(=O)OC)C(=O)N1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL2105032 |
